Show simple item record

Dupilumab therapy following JAK inhibitor withdrawal in moderate-severe atopic dermatitis.

dc.contributor.authorKiely, Lisa
dc.contributor.authorO'Connor, Cathal
dc.contributor.authorMurphy, Michelle
dc.date.accessioned2024-06-27T09:03:28Z
dc.date.available2024-06-27T09:03:28Z
dc.date.issued2022-08-08
dc.identifier.pmid35906850
dc.identifier.doi10.1111/dth.15750
dc.identifier.urihttp://hdl.handle.net/10147/641779
dc.language.isoenen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectatopic dermatitisen_US
dc.titleDupilumab therapy following JAK inhibitor withdrawal in moderate-severe atopic dermatitis.en_US
dc.typeOtheren_US
dc.identifier.eissn1529-8019
dc.identifier.journalDermatologic therapyen_US
dc.source.journaltitleDermatologic therapy
dc.source.volume35
dc.source.issue10
dc.source.beginpagee15750
dc.source.endpage
refterms.dateFOA2024-06-27T09:03:30Z
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
DTH-35-e15750.pdf
Size:
403.5Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International